Filing Flows › OptimizeRx (OPRX) › Gross margin
OptimizeRx (OPRX) gross margin by quarter
OptimizeRx's gross margin was 74.8% in Q4 2025 (fourth quarter 2025), +7.6 pts from Q3 2025. Over the last 3 quarters it ranged from 63.8% (Q2 2025) to 74.8% (Q4 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | 74.8% | +7.6 pts | — |
| Q3 2025 | 67.2% | +3.4 pts | — |
| Q2 2025 | 63.8% | — | — |
Q4 2025 at a glance
OptimizeRx, Q4 2025: revenue $32.2M (-0.2% year over year), operating margin 26.6%, net earnings $5.0M, operating cash flow $7.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is OptimizeRx's gross margin?
OptimizeRx's gross margin was 74.8% in Q4 2025 (fourth quarter 2025), +7.6 pts from Q3 2025.
How has OptimizeRx's gross margin changed?
Over the last 3 quarters it ranged from 63.8% (Q2 2025) to 74.8% (Q4 2025).